Arlington Capital Partners Announces the Acquisition of AVS Bio
Go back to Arlington Capital Partners Announces the Acquisition of AVS Bio| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 293.09 +3.09 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.00 | 52 Week High | $89.18 | |||
| Open | $285.72 | 52 Week Low | $65.70 | |||
| Day High | $294.41 | P/E | 136.32 | |||
| Day Low | $281.73 | EPS | $2.15 | |||
| Volume | 189,097 | |||||

